Skip to main content

Table 1 The expression quantification of β-actin and HSPs by the unique Leu-containing isotope peptides in MS

From: Downregulated expression of HSP27 in human low-grade glioma tissues discovered by a quantitative proteomic analysis

  

MOWSE scores(b) (Queries Match)

SILAC-Ratio(e) (mean ± SD; No. of Pep f )

Unique Leu-containing peptide coverage(%)

 

Protein name

IPI no.(a)

HGTs (c)

PBTs (d)

Ratio1

Ratio2

HGTs (c)

PBTs (d)

Change-Ratio(g) (ratio1/ratio2)

HSP110/100 family

        

HSP H1(105 KD)

IPI00218993

77(8)

140(10)

0.61 ± 0.02 (2)

0.82 ± 0 (1)

2.7

1.6

0.74

HSP90 family

        

HSP90 AB1

IPI00334775

428(18)

179(10)

0.29 ± 0.17 (6)

0.45 ± 0.26 (3)

8.7

4.8

0.64

HSP90 AA1

IPI00382470

82(14)

109(11)

0.80 ± 0.43 (4)

0.75 ± 0.52 (2)

6

3

1.07

HSP70 family

        

HSP A8(71 KD)

IPI00003865

486(16)

360(17)

0.52 ± 0.09 (8)

0.55 ± 0.1(3)

17

5

0.95

HSP A9(70 KD)

IPI00007765

401(16)

127(5)

0.49 ± 0.09 (5)

0.34 ± 0 (1)

9.6

2.2

1.44

HSP A5(70 KD)

IPI00003362

508 (15)

99(8)

0.33 ± 0.15 (7)

0.57 ± 0.28 (2)

14

3.2

0.58

HSP60 family

        

HSP D1(60 KD)

IPI00472102

67(9)

419(20)

0.57 ± 0.08 (3)

0.52 ± 0.27(4)

33

18

1.10

Small HSP family

        

HSP B1(27 KD)

IPI00025512

159(12)

138 (10)

0.29 ± 0.12 (4)

0.61 ± 0.32 (3)

8.2

7

0.48

Control protein

        

β-actin

IPI00021439

687(31)

643(39)

1.03 ± 0.02 (4)

0.98 ± 0.03 (4)

12

12

1.05

  1. (a) IPI (International Protein Index) no. is the protein accession number, which was derived from the EMBL-EBI database.
  2. (b) 'MOWSE' is derived from molecular weight search, and it is a method for the identification of proteins from the molecular masses of peptides created by proteolytic digestion and measured by MS.
  3. (c) The protein mixture from HGTs and Leu-d3labeling H4 cells; HGTs: human glioma tissues.
  4. (d) The protein mixture from PBTs and Leu-d3labeling H4 cells; PBTs: para-cancerous brain tissues.
  5. (e) SILAC ratio1 (HGTs/H4) and SILAC ratio2 (PBTs/H4): the peak intensity ratio of Leu-d0-labeling peptides from HGTs or PBTs versus that of Leu-d3-labeling peptides from H4 cells, which was quantified using Analyst QS software.
  6. (f) The number of unique Leu-containing peptides of one protein to calculate SILAC ratio1 and SILAC ratio2.
  7. (g) The Change-Ratio between two tissues (SILAC Ratio1/SILAC Ratio2).